{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:39:52Z","timestamp":1761061192335},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Das diabetische Fu\u00dfsyndrom (DFS) ist die h\u00e4ufigste Ursache einer Majoramputation in Deutschland. Die meisten Fu\u00dfl\u00e4sionen werden durch repetitive Druckbelastung bei diabetischer Polyneuropathie ausgel\u00f6st. Die periphere arterielle Verschlusskrankheit (PAVK) verhindert die Wundheilung und ist Hauptrisikofaktor f\u00fcr Amputationen. Bei der Therapie sind die Wund- und Infektionsbehandlung sowie die zeitnahe Revaskularisation entscheidend. Der Einsatz endovaskul\u00e4rer und gef\u00e4\u00dfchirurgischer Methoden ist abh\u00e4ngig von Verteilungsmuster und L\u00e4nge der Verschlussprozesse. Beide Verfahren erg\u00e4nzen sich. Die Bypasschirurgie hat beim neuroisch\u00e4mischen DFS einen hohen Stellenwert. Multidisziplin\u00e4re Zentren, die Revaskularisationen bei DFS anbieten, k\u00f6nnen in 90\u202f% der F\u00e4lle eine Verbesserung der arteriellen Durchblutung erreichen und die Amputationsrate um bis zu 80\u202f% senken. Wegen der hohen Rezidivrate diabetischer Fu\u00dfl\u00e4sionen sind Ma\u00dfnahmen zur Sekund\u00e4rprophylaxe von herausragender Bedeutung (podologische und orthop\u00e4dietechnische Betreuung, Fu\u00dfchirurgie).<\/jats:p>","DOI":"10.1007\/s00104-020-01313-5","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:02:57Z","timestamp":1606287777000},"page":"173-186","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diabetisches Fu\u00dfsyndrom \u2013 Teil\u00a02","Diabetic foot syndrome\u2014Part\u00a02"],"prefix":"10.1007","volume":"92","author":[{"name":"Kommission PAVK und Diabetisches Fu\u00dfsyndrom der DGG e.\u202fV.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"R\u00fcmenapf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Rother","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"G\u00f6rtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"B\u00f6ckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hochlenert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hohneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00104-020-01301-9","author":"G R\u00fcmenapf","year":"2020","unstructured":"R\u00fcmenapf\u00a0G, Morbach\u00a0S, Rother\u00a0U, Uhl\u00a0C, G\u00f6rtz\u00a0H, B\u00f6ckler\u00a0D et al (2020) Kommission PAVK und Diabetisches Fu\u00dfsyndrom der DGG e.\u202fV. Diabetisches Fu\u00dfsyndrom\u00a0\u2013 Teil\u00a01. Definition, Pathophysiologie, Diagnostik und Klassifikation. Chirurg. https:\/\/doi.org\/10.1007\/s00104-020-01301-9","journal-title":"Chirurg"},{"key":"1313_CR2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","volume":"366","author":"AJM Boulton","year":"2005","unstructured":"Boulton\u00a0AJM, Vileikyte\u00a0L, Ragnarson-Tennvall\u00a0G, Apequist\u00a0J (2005) The global burden of diabetic foot disease. Lancet 366:1719\u20131724","journal-title":"Lancet"},{"key":"1313_CR3","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong\u00a0DG, Boulton\u00a0AJM, Bus\u00a0SA (2017) Diabetic foot ulcers and their recurrence. N\u00a0Engl J Med 376:2367\u20132375","journal-title":"N Engl J Med"},{"key":"1313_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","volume":"51","author":"L Prompers","year":"2008","unstructured":"Prompers\u00a0L, Schaper\u00a0N, Apelqvist\u00a0J et\u00a0al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51:747\u2013775","journal-title":"Diabetologia"},{"issue":"2","key":"1313_CR5","first-page":"181","volume":"12","author":"S Morbach","year":"2017","unstructured":"Morbach\u00a0S, M\u00fcller\u00a0E, Reike\u00a0H, Risse\u00a0A, R\u00fcmenapf\u00a0G, Spraul\u00a0M (2017) Diabetisches Fu\u00dfsyndrom. Diabetol Stoffwechs 12(2):181\u2013189","journal-title":"Diabetol Stoffwechs"},{"key":"1313_CR6","first-page":"B591","volume":"104","author":"H Bauer","year":"2007","unstructured":"Bauer\u00a0H, Germann\u00a0G, Gries\u00a0FA, Morbach\u00a0S, Riepe\u00a0G, Rothe\u00a0U, R\u00fcmenapf\u00a0G, Stiegler\u00a0H, Tepe\u00a0G, Uebel\u00a0T, Weck\u00a0M, Witte\u00a0M (2007) Nationale VersorgungsLeitlinie Typ-2-Diabetes \u2013 Pr\u00e4vention und Therapie von Fu\u00dfkomplikationen. Dtsch Arztebl 104:B591\u2013B598","journal-title":"Dtsch. Arztebl."},{"issue":"2","key":"1313_CR7","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.jvs.2015.10.085","volume":"63","author":"A Hingorani","year":"2016","unstructured":"Hingorani\u00a0A (2016) The management of diabetic foot: a\u00a0clinical practice guideline by the society of vascular surgery in collaboration with the American podiatric medical association and the society for vascular medicine. J\u00a0Vasc Surg 63(2):1S\u201368S","journal-title":"J Vasc Surg"},{"key":"1313_CR8","unstructured":"IWGDF (2019) 2019 IWGDF guidelines on the prevention and management of diabetic foot disease. www.iwgdfguidelines.org. Zugegriffen 05.06.2020"},{"key":"1313_CR9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/CLEP.S146484","volume":"10","author":"H Claessen","year":"2018","unstructured":"Claessen\u00a0H, Narres\u00a0M, Haastert\u00a0B, Arend\u00a0W, Hoffmann\u00a0F, Morbach\u00a0S, R\u00fcmenapf\u00a0G, Kvitkina\u00a0T, Friedel\u00a0H, G\u00fcnster\u00a0C, Schubert\u00a0I, Ullrich\u00a0W, Westerhoff\u00a0B, Wilk\u00a0A, Icks\u00a0A (2018) Lower-extremity amputations in people with and without diabetes in Germany, 2008\u20132012\u2014an analysis of more than 30\u00a0million inhabitants. Clin Epidemiol 10:475\u2013488","journal-title":"Clin Epidemiol"},{"issue":"7","key":"1313_CR10","first-page":"130","volume":"114","author":"K Kr\u00f6ger","year":"2017","unstructured":"Kr\u00f6ger\u00a0K, Berg\u00a0C, Santosa\u00a0F, Malyar\u00a0N, Reinecke\u00a0H (2017) Lower limb amputation in Germany. Dtsch Arztebl Int 114(7):130\u2013136","journal-title":"Dtsch Arztebl Int"},{"key":"1313_CR11","first-page":"729","volume":"113","author":"H Lawall","year":"2016","unstructured":"Lawall\u00a0H, Huppert\u00a0P, Espinola-Klein\u00a0C, R\u00fcmenapf\u00a0G (2016) Clinical practice guideline\u2014the diagnosis and treatment of peripheral arterial disease. Dtsch Arztebl Int 113:729\u2013736","journal-title":"Dtsch Arztebl Int"},{"key":"1313_CR12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc17-1683","volume":"41","author":"BK Fesseha","year":"2018","unstructured":"Fesseha\u00a0BK, Abularrage\u00a0CJ, Hines\u00a0KF et\u00a0al (2018) Association of hemoglobin A1c and wound healing in diabetic foot ulcers. Diabetes Care 41:1478\u20131485","journal-title":"Diabetes Care"},{"key":"1313_CR13","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-43944-9","volume-title":"Das diabetische Fu\u00dfsyndrom \u2013 \u00dcber die Entit\u00e4t zur Therapie","author":"D Hochlenert","year":"2014","unstructured":"Hochlenert\u00a0D, Engels\u00a0G, Morbach\u00a0S (2014) Das diabetische Fu\u00dfsyndrom \u2013 \u00dcber die Entit\u00e4t zur Therapie. Springer, Heidelberg. ISBN 978-3-662-43943\u20112","ISBN":"http:\/\/id.crossref.org\/isbn\/9783662439432"},{"issue":"1","key":"1313_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/dmrr.2700","volume":"32","author":"FL Game","year":"2016","unstructured":"Game\u00a0FL, Attinger\u00a0C, Hartemann\u00a0A et\u00a0al (2016) IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 32(1):75\u201383","journal-title":"Diabetes Metab Res Rev"},{"key":"1313_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2213-8587(17)30438-2","volume":"6","author":"M Edmonds","year":"2018","unstructured":"Edmonds\u00a0M, Lazaro-Martinez\u00a0JL, Alfayate-Garcia\u00a0JM et al (2018) Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol 6:186\u2013196","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"1313_CR16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-8587(18)30240-7","volume":"6","author":"F Game","year":"2018","unstructured":"Game\u00a0F, Jeffcoate\u00a0W, Tarnow\u00a0L, Jacobsen\u00a0JL, Whitham\u00a0DJ, Harrison\u00a0EF, Ellender\u00a0SJ, Fitzsimmons\u00a0D, L\u00f6ndahl\u00a0M (2018) Leucopatch II trial team. Leucopatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol 6(11):870\u2013878","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1313_CR17","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s00132-009-1502-y","volume":"38","author":"G R\u00fcmenapf","year":"2009","unstructured":"R\u00fcmenapf\u00a0G, Lang\u00a0W, Morbach\u00a0S (2009) Minoramputationen beim diabetischen Fu\u00dfsyndrom. Orthopade 38:1160\u20131170","journal-title":"Orthopade"},{"issue":"5","key":"1313_CR18","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jvs.2014.12.005","volume":"61","author":"A Meyer","year":"2015","unstructured":"Meyer\u00a0A, Goller\u00a0K, Horch\u00a0RE et\u00a0al (2015) Results of combined vascular reconstruction and free flap transfer for limb salvage in patients with critical limb ischemia. J\u00a0Vasc Surg 61(5):1239\u20131248","journal-title":"J Vasc Surg"},{"key":"1313_CR19","volume-title":"IWGDF guideline on the diagnosis and treatment of foot infection in persons with diabetes","author":"BA Lipsky","year":"2019","unstructured":"Lipsky\u00a0BA, Senneville\u00a0E, Abbas\u00a0ZG et\u00a0al (2019) IWGDF guideline on the diagnosis and treatment of foot infection in persons with diabetes"},{"issue":"2","key":"1313_CR20","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1078-5884(11)60012-9","volume":"42","author":"M Lep\u00e4ntalo","year":"2011","unstructured":"Lep\u00e4ntalo\u00a0M, Apelquist\u00a0J, Setacci\u00a0C, Ricco\u00a0JB, de Donato\u00a0G, Becker\u00a0F, Robert-Ebadi\u00a0H, Cao\u00a0P, Eckstein\u00a0HH, De Rango\u00a0P, Diehm\u00a0N, Schmidli\u00a0J, Teraa\u00a0M, Moll\u00a0FL, Dick\u00a0F, Davies\u00a0AH (2011) Chapter V: diabetic foot. Clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Surg 42(2):S60\u2013S74","journal-title":"Eur J Vasc Surg"},{"key":"1313_CR21","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1161\/hc4201.097943","volume":"104","author":"G Dorros","year":"2001","unstructured":"Dorros\u00a0G, Jaff\u00a0MR, Dorros\u00a0AM, Mathiak\u00a0LM, He\u00a0T (2001) Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235\u00a0patients with critical limb ischemia: five-year follow-up. Circulation 104:2057","journal-title":"Circulation"},{"key":"1313_CR22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s001250051459","volume":"43","author":"P Holstein","year":"2000","unstructured":"Holstein\u00a0P, Ellitsgaard\u00a0N, Olsen\u00a0BB, Ellitsgaard\u00a0V (2000) Decreasing incidence of major amputations in people with diabetes. Diabetologia 43:844\u2013847","journal-title":"Diabetologia"},{"issue":"4","key":"1313_CR23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvs.2015.04.441","volume":"62","author":"T Bisdas","year":"2015","unstructured":"Bisdas\u00a0T, Borowski\u00a0M, Torsello\u00a0G (2015) Current practice of first-line treatment strategies in patients with critical limb ischemia. J\u00a0Vasc Surg 62(4):965\u2013973","journal-title":"J Vasc Surg"},{"issue":"2","key":"1313_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1024\/0301-1526\/a000831","volume":"49","author":"J Stella","year":"2020","unstructured":"Stella\u00a0J, Engelbertz\u00a0C, Gebauer\u00a0K, Hassu\u00a0J, Meyborg\u00a0M, Freisinger\u00a0E, Malyar\u00a0NM (2020) Outcome of patients with chronic limb-threatening ischemia with and without revascularization. Vasa 49(2):121\u2013127","journal-title":"Vasa"},{"key":"1313_CR25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren\u00a0L, Hiatt\u00a0WR, Dormandy\u00a0JA, Nehler\u00a0MR, Harris\u00a0KA, Fowkes\u00a0FGR (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33:S1\u2013S75","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1024\/0301-1526\/a0000235","volume":"42","author":"G R\u00fcmenapf","year":"2013","unstructured":"R\u00fcmenapf\u00a0G, Geiger\u00a0S, Schneider\u00a0B, Amendt\u00a0K, Wilhelm\u00a0N, Morbach\u00a0S, Nagel\u00a0N (2013) Readmissions of patients with diabetes and foot ulcers after infra-popliteal bypass surgery: attacking the problem by an integrated case management model. Vasa 42:56\u201367. https:\/\/doi.org\/10.1024\/0301-1526\/a0000235","journal-title":"Vasa"},{"key":"1313_CR27","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jvs.2008.07.004","volume":"48","author":"VS Kashyap","year":"2008","unstructured":"Kashyap\u00a0VS et\u00a0al (2008) The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J\u00a0Vasc Surg 48:1451\u20131457","journal-title":"J Vasc Surg"},{"key":"1313_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","volume":"55","author":"V Aboyans","year":"2018","unstructured":"Aboyans\u00a0V, Ricco\u00a0JB, Bartelink\u00a0MEL et\u00a0al (2018) 2017 guidelines ob the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55:305\u2013368","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1313_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiol.2211010039","volume":"221","author":"G Muradin","year":"2001","unstructured":"Muradin\u00a0G, Bosch\u00a0J, Stijnen\u00a0T, Hunink\u00a0M (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221:137\u2013145","journal-title":"Radiology"},{"key":"1313_CR30","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger\u00a0M, Sabeti\u00a0S, Loewe\u00a0C, Dick\u00a0P, Amighi\u00a0J, Mlekusch\u00a0W et\u00a0al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N\u00a0Engl J Med 354:1879\u20131888","journal-title":"N Engl J Med"},{"key":"1313_CR31","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","volume":"51","author":"AW Bradbury","year":"2010","unstructured":"Bradbury\u00a0AW, Adam\u00a0DJ, Bell\u00a0J et al (2010) Bypass versus angioplasty in severe Ischaemia oft he leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a\u00a0bypass surgery-first or a\u00a0balloon angioplasty-first revascularization strategy. J\u00a0Vasc Surg 51:5S\u201317S","journal-title":"J Vasc Surg"},{"key":"1313_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00268-007-9309-7","volume":"32","author":"A Kechagias","year":"2008","unstructured":"Kechagias\u00a0A, Yl\u00f6nen\u00a0K, Biancari\u00a0F (2008) Long-term outcome after isolated endarterectomy of the femoral bifurcation. World J Surg 32:51\u201354","journal-title":"World J Surg"},{"key":"1313_CR33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jvs.2009.05.053","volume":"50","author":"G Al-Khoury","year":"2009","unstructured":"Al-Khoury\u00a0G et al (2009) Isolated femoral endarterectomy: impact of SFA TASC classification on recurrence of symptoms and need for additional intervention. J\u00a0Vasc Surg 50:784\u2013789","journal-title":"J Vasc Surg"},{"key":"1313_CR34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jvs.2008.01.005","volume":"47","author":"M Romiti","year":"2008","unstructured":"Romiti\u00a0M et al (2008) Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J\u00a0Vasc Surg 47:975\u2013981","journal-title":"J Vasc Surg"},{"key":"1313_CR35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/SLA.0b013e3181fc3c73","volume":"252","author":"MI S\u00f6derstr\u00f6m","year":"2010","unstructured":"S\u00f6derstr\u00f6m\u00a0MI et al (2010) Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a\u00a0propensity score analysis. Ann Surg 252:765\u2013763","journal-title":"Ann Surg"},{"key":"1313_CR36","volume-title":"IWGDF Guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a\u00a0foot ulcer and diabetes","author":"RJ Hinchliffe","year":"2019","unstructured":"Hinchliffe\u00a0RJ, Forsythe\u00a0RO, Apelquist\u00a0J et\u00a0al (2019) IWGDF Guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a\u00a0foot ulcer and diabetes"},{"key":"1313_CR37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejvs.2012.09.007","volume":"44","author":"A Lejay","year":"2012","unstructured":"Lejay\u00a0A, Thaveau\u00a0F, Georg\u00a0Y, Bajcz\u00a0C, Kretz\u00a0JG, Chafk\u00e9\u00a0N (2012) Autonomy following revascularisation in 80-year-old patients with critical limb ischemia. Eur J Vasc Endovasc Surg 44:562\u2013567","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1313_CR38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2005.11.025","volume":"43","author":"M Albers","year":"2006","unstructured":"Albers\u00a0M, Romiti\u00a0M, Brochado-Neto\u00a0FC, De Luccia\u00a0N, Pereira\u00a0CA (2006) Meta-analysis of popliteo-to-distal vein bypass grafts for critical ischemia. J\u00a0Vasc Surg 43:498\u2013503","journal-title":"J Vasc Surg"},{"key":"1313_CR39","first-page":"980","volume":"90","author":"FJ Veith","year":"1981","unstructured":"Veith\u00a0FJ, Gupta\u00a0SK, Samson\u00a0RH, Flores\u00a0SW, Janko\u00a0G, Scher\u00a0LA (1981) Superficial femoral and popliteal arteries as inflow sites for distal bypasses. Surgery 90:980\u2013990","journal-title":"Surgery"},{"key":"1313_CR40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jvs.2005.11.016","volume":"43","author":"SN Haider","year":"2006","unstructured":"Haider\u00a0SN et\u00a0al (2006) Two year outcome with preferential use of infrainguinal angioplasty for critical ischemia. J\u00a0Vasc Surg 43:504\u2013512","journal-title":"J Vasc Surg"},{"key":"1313_CR41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ccd.22658","volume":"76","author":"A Schmidt","year":"2010","unstructured":"Schmidt\u00a0A, Ulrich\u00a0M, Winkler\u00a0B et al (2010) Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 76:1047\u20131054","journal-title":"Catheter Cardiovasc Interv"},{"key":"1313_CR42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.avsg.2007.12.012","volume":"22","author":"KI Paraskevas","year":"2008","unstructured":"Paraskevas\u00a0KI, Baker\u00a0DM, Pompella\u00a0A, Mikhailidis\u00a0DP (2008) Does diabetes mellitus play a\u00a0role in restenosis and patency rates following lower extremity peripheral arterial revascularization? Ann Vasc Surg 22:481\u2013491","journal-title":"Ann Vasc Surg"},{"key":"1313_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jvs.2012.04.011","volume":"56","author":"JB Wallaert","year":"2012","unstructured":"Wallaert\u00a0JB, Nolan\u00a0BW, Adams\u00a0J et al (2012) The impact of diabetes on postoperative outcomes following lower-extremity bypass surgery. J\u00a0Vasc Surg 56:1317\u20131323","journal-title":"J Vasc Surg"},{"key":"1313_CR44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jvs.2016.08.099","volume":"65","author":"U Rother","year":"2017","unstructured":"Rother\u00a0U, Krenz\u00a0K, Lang\u00a0W, Horch\u00a0RE, Schmid\u00a0A, Heinz\u00a0M, Meyer\u00a0A, Regus\u00a0S (2017) Immediate changes of angiosome perfusion during tibial angioplasty. J\u00a0Vasc Surg 65:422\u2013430","journal-title":"J Vasc Surg"},{"issue":"6","key":"1313_CR45","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jvs.2010.01.092","volume":"51","author":"HH Dosluoglu","year":"2010","unstructured":"Dosluoglu\u00a0HH, Lall\u00a0P, Cherr\u00a0GS, Harris\u00a0LM, Dryjski\u00a0ML (2010) Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease. J\u00a0Vasc Surg 51(6):1425\u20131435.e1. https:\/\/doi.org\/10.1016\/j.jvs.2010.01.092","journal-title":"J Vasc Surg"},{"key":"1313_CR46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejvs.2019.06.029","volume":"58","author":"S Hischke","year":"2019","unstructured":"Hischke\u00a0S, Rie\u00df\u00a0HC, Bublitz\u00a0MK, Kriston\u00a0L, Schwandeberg\u00a0T, H\u00e4rter\u00a0M, Bertges\u00a0D, Debus\u00a0ES, Behrendt\u00a0CA (2019) Quality indicators in peripheral arterial occlusive disease treatment:a systematic review. Eur J Vasc Endovasc Surg 58:738\u2013745","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1313_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1078-5884(96)80044-X","volume":"11","author":"M Lep\u00e4ntalo","year":"1996","unstructured":"Lep\u00e4ntalo\u00a0M, M\u00e4tzke\u00a0S (1996) Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 11:153\u2013157","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1313_CR48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2006.03.026","volume":"44","author":"WA Marston","year":"2006","unstructured":"Marston\u00a0WA, Davies\u00a0SW, Armstrong\u00a0B, Farbr\u00a0MA, Mendes\u00a0RC, Fulton\u00a0JJ et\u00a0al (2006) Natural history of limbs with arterial insufficiency and cronic ulceration treated without revascularization. J\u00a0Vasc Surg 44:108\u2013114","journal-title":"J Vasc Surg"},{"key":"1313_CR49","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jvs.2010.04.057","volume":"52","author":"RW Sprengers","year":"2010","unstructured":"Sprengers\u00a0RW, Teraa\u00a0M, Moll\u00a0FL, Ardine de Witt\u00a0G, van der Graaf\u00a0Y, Verhaar\u00a0MC (2010) Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J\u00a0Vasc Surg 52:843\u2013849","journal-title":"J Vasc Surg"},{"key":"1313_CR50","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-2003-42746","volume":"128","author":"K W\u00f6lfle","year":"2003","unstructured":"W\u00f6lfle\u00a0K, Schaal\u00a0J, Rittler\u00a0S, Bruijnen\u00a0H, Loeprecht\u00a0H (2003) Infrainguinal bypass grafting in patients with end-stage renal disease and critical limb ischaemia: is it worthwhile? Zentralbl Chir 128:709\u2013714","journal-title":"Zentralbl Chir"},{"issue":"16","key":"1313_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.118.009724","volume":"7","author":"JA Mustapha","year":"2018","unstructured":"Mustapha\u00a0JA, Katzen\u00a0BT, Neville\u00a0RF, Lookstein\u00a0RA, Zeller\u00a0T, Miller\u00a0LE, Jaff\u00a0MR (2018) Determinants of long-term outcomes and costs in the management of critical limb ischemia: a\u00a0population-based cohort study. J\u00a0Am Heart Assoc 7(16):1\u201311","journal-title":"J Am Heart Assoc"},{"key":"1313_CR52","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","volume":"62","author":"AM Abu Dabrh","year":"2015","unstructured":"Abu Dabrh\u00a0AM, Steffen\u00a0M, Undavalli\u00a0C, Asi\u00a0N, Wang\u00a0Z, Elamin\u00a0MB, Conte\u00a0M, Murad\u00a0MH (2015) The natural history of untreated severe or critical limb ischemia. J\u00a0Vasc Surg 62:1642\u20131651","journal-title":"J Vasc Surg"},{"key":"1313_CR53","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/dc15-0536","volume":"38","author":"O Hoffstad","year":"2015","unstructured":"Hoffstad\u00a0O, Mitra\u00a0N, Walsh\u00a0J, Margolis\u00a0DJ (2015) Diabetes, lower-extremity amputation, and death. Diabetes Care 38:1852\u20131857","journal-title":"Diabetes Care"},{"issue":"2","key":"1313_CR54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1534734617704083","volume":"16","author":"DK Wukich","year":"2017","unstructured":"Wukich\u00a0DK, Ahn\u00a0J, Raspovic\u00a0KM, La Fontaine\u00a0J, Lavery\u00a0LA (2017) Improved quality of life after transtibial amputation in patients with diabetes-related fooot complications. Int J Low Extrem Wounds 16(2):114\u2013121","journal-title":"Int J Low Extrem Wounds"},{"key":"1313_CR55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-5214(03)00092-2","volume":"38","author":"MR Nehler","year":"2003","unstructured":"Nehler\u00a0MR, Coll\u00a0JR, Hiatt\u00a0WR, Regensteiner\u00a0JG, Schnickel\u00a0GT, Klenke\u00a0WA, Strecker\u00a0PK, Anderson\u00a0MW, Jones\u00a0DN, Whitehill\u00a0TA, Moskowitz\u00a0S, Krupski\u00a0WC (2003) Functional outcome in a\u00a0contemporary series of major lower extremity amputations. J\u00a0Vasc Surg 38:7\u201314","journal-title":"J Vasc Surg"},{"key":"1313_CR56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jdiacomp.2011.02.001","volume":"25","author":"KK Evans","year":"2011","unstructured":"Evans\u00a0KK, Attinger\u00a0CE, Al-Attar\u00a0A et al (2011) The importance of limb preservation in the diabetic population. J\u00a0Diabetes Complications 25:227\u2013231","journal-title":"J Diabetes Complications"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-020-01313-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T08:44:27Z","timestamp":1613033067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-020-01313-5"}},"subtitle":["Revaskularisation, Behandlungsalternativen, Versorgungsstrukturen, Rezidivprophylaxe","Revascularization, treatment alternatives, care structures, recurrency prophylaxis"],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s00104-020-01313-5","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"type":"print","value":"0009-4722"},{"type":"electronic","value":"1433-0385"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"25 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>G.\u00a0R\u00fcmenapf<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Chefarzt der Klinik f\u00fcr Gef\u00e4\u00dfchirurgie, Diakonissen Speyer, Diakonissen-Stiftungs-Krankenhaus Speyer. <b>S.\u00a0Morbach<\/b>: Finanzielle Interessen: Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00e4.: Nationales Advisory Boards der Firmen Novo Nordisk sowie URGO GmbH, jeweils ein bis zwei ganzt\u00e4gige Treffen pro Jahr. Nichtfinanzielle Interessen: Angestellter Diabetologe\/Angiologe (Chefarzt), Marienkrankenhaus Soest, Erm\u00e4chtigungsambulanz f\u00fcr Patienten mit Diabetischem Fu\u00dfsyndrom, Marienkrankenhaus Soest, Gastwissenschaftler Institut f\u00fcr Versorgungsforschung und Gesundheits\u00f6konomie Heinrich-Heine-Universit\u00e4t, D\u00fcsseldorf | Mitgliedschaften: Deutsche Diabetes Gesellschaft (DDG, AG Diabetischer Fu\u00df), Europ\u00e4ische Diabetes Gesellschaft (EASD, Diabetic Foot Study Group), Deutsche Gesellschaft f\u00fcr Innere Medizin, Deutsche Gesellschaft f\u00fcr Angiologie, Deutsche Gesellschaft f\u00fcr Wundbehandlung und Wundheilung (DGfW), Nominating Committee als Past Vize-Pr\u00e4sident D\u2011Foot International. <b>U.\u00a0Rother<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Oberarzt am Universit\u00e4tsklinikum Erlangen | Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (DGG e.\u202fV.). <b>C.\u00a0Uhl<\/b>: Finanzielle Interessen: Reise- und \u00dcbernachtungskosten sowie Teilnahmegeb\u00fchren: Fa. Cook, Medtronic, Gore. Nichtfinanzielle Interessen: Oberarzt, Angestellter Gef\u00e4\u00dfchirurg, Klinik f\u00fcr Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Heidelberg | Mitgliedschaft: DGG. <b>H.\u00a0G\u00f6rtz<\/b>: Finanzielle Interessen: Referentenhonorar: Fa. NOWECOR. \u2013 F\u00fcr Tutoren und Referentent\u00e4tigkeit im Rahmen endovaskul\u00e4rer Kurse: Fa. APIUM. Nichtfinanzielle Interessen: Chefarzt Gef\u00e4\u00dfchirurgie, Bonifatiushospital Lingen | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (Leiter der Sektion f\u00fcr Endovaskul\u00e4re Techniken, Kommission pAVK und Diabetischer Fu\u00df). <b>D.\u00a0B\u00f6ckler<\/b>: Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: W.L. Gore & Ass. | Siemens Healtheneers. \u2013 Honorar als Referent auf Kongressen: W.L, Gore & Ass, Medtronic, Siemens. \u2013 Wissenschaftlicher Berater: W.L Gore & Ass., Medtronic. Nichtfinanzielle Interessen: \u00c4rztlicher Direktor der Klinik f\u00fcr Gef\u00e4\u00dfchirurgie und Endovaskul\u00e4re Chirurgie, Universit\u00e4tsklinikum Heidelberg | Mitgliedschaften: Pr\u00e4sident der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin e.\u202fV. (2019\u20132020). <b>C.A.\u00a0Behrendt<\/b>: Finanzielle Interessen: Gef\u00f6rdert durch den Innovationsfond des Gemeinsamen Bundesausschusses (IDOMENEO, 01VSF16008 und RABATT, 01VSF18035). Nichtfinanzielle Interessen: Oberarzt der Gef\u00e4\u00dfchirurgie in universit\u00e4rer Anstellung, Leiter der Forschungsgruppe GermanVasc, wissenschaftlicher Berater von benannten Stellen und Instituten bei der Evaluation von Richtlinien | Chair des VASCUNET Committee, Chair des Medical Device Epidemiology Network (MDEpiNet) Chapter Germany | Mitgliedschaften: Fellow Member der European Society for Vascular Surgery (ESVS), International Elected Member der Society for Vascular Surgery (SVS), PAVK und DFS Kommission der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (DGG), Editorial Board des European Journal of Vascular and Endovascular Surgery, Editorial Board der VASA European Journal of Vascular Medicine. <b>M.\u00a0Sigl<\/b>: Finanzielle Interessen: Referentenhonorare: Fa. Pfizer Pharma GmbH, Aspen GmbH. \u2013 Beraterhonorare: Bayer Vital GmbH, Rheacell GmbH & Co. KG. Nichtfinanzielle Interessen: Angestellter Angiologe, Oberarzt, Leiter Bereich Angiologie, Universit\u00e4tsmedizin Mannheim | Mitgliedschaften: DGIM, Deutsche Gesellschaft f\u00fcr Angiologie (DGA). <b>D.\u00a0Hochlenert, G.\u00a0Engels <\/b>und<b> A.\u00a0Hohneck<\/b> geben an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}